XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.1
OTHER FINANCIAL INFORMATION Condensed Cash Flow Statement (Tables)
3 Months Ended
Mar. 31, 2019
Condensed Cash Flow Statements, Captions [Line Items]  
Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2018
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash provided by (used in) operating activities
$
5,497

 
$
57,694

 
$
(10,198
)
 
$

 
$
52,993

Investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures

 
(2,954
)
 
(4,708
)
 

 
(7,662
)
Dividends received from subsidiaries

 
22,744

 

 
(22,744
)
 

Other

 
(18,908
)
 
(8,760
)
 
18,908

 
(8,760
)
Net cash provided by (used in) investing activities

 
882

 
(13,468
)
 
(3,836
)
 
(16,422
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings

 
58,000

 
515,663

 
(22,744
)
 
550,919

Repayments
(3,836
)
 
(90,000
)
 
(477,220
)
 
3,836

 
(567,220
)
Repurchases of common stock
(1,661
)
 

 

 

 
(1,661
)
Dividends paid by subsidiaries

 

 
(22,744
)
 
22,744

 

Decrease in bank overdrafts

 
(10,575
)
 

 

 
(10,575
)
Other

 
(290
)
 

 

 
(290
)
Net cash (used in) provided by financing activities
(5,497
)
 
(42,865
)
 
15,699

 
3,836

 
(28,827
)
Effect of exchange rate changes on cash and cash equivalents

 

 
(1,800
)
 

 
(1,800
)
Net change in cash and cash equivalents

 
15,711

 
(9,767
)
 

 
5,944

Cash and cash equivalents at the beginning of period

 
50,602

 
67,351

 

 
117,953

Cash and cash equivalents at the end of period
$

 
$
66,313

 
$
57,584

 
$

 
$
123,897

 
Condensed Consolidating Statement of Cash Flows
 
Three Months Ended
 
March 31, 2019
 
 
 
 
 
 
 
 
 
 
(In thousands)
WESCO
International,
Inc.
 
WESCO
Distribution,
Inc.
 
Non-Guarantor
Subsidiaries
 
Consolidating
and Eliminating
Entries
 
Consolidated
Net cash (used in) provided by operating activities
$
5,157

 
$
27,122

 
$
(3,410
)
 
$

 
$
28,869

Investing activities:

 

 

 

 

Acquisition payments

 
(27,742
)
 

 

 
(27,742
)
Capital expenditures

 
(2,513
)
 
(8,315
)
 

 
(10,828
)
Dividends received from subsidiaries

 
22,095

 

 
(22,095
)
 

Other

 
(19,510
)
 
53

 
19,510

 
53

Net cash used in investing activities

 
(27,670
)
 
(8,262
)
 
(2,585
)
 
(38,517
)
Financing activities:
 
 
 
 
 
 
 
 
 
Borrowings

 
139,134

 
330,196

 
(22,095
)
 
447,235

Repayments
(2,585
)
 
(140,134
)
 
(289,674
)
 
2,585

 
(429,808
)
Repurchases of common stock
(2,572
)
 

 

 

 
(2,572
)
Dividends paid by subsidiaries

 

 
(22,095
)
 
22,095

 

Increase in bank overdrafts

 
4,639

 

 

 
4,639

Other

 
(248
)
 

 

 
(248
)
Net cash provided by (used in) financing activities
(5,157
)
 
3,391

 
18,427

 
2,585

 
19,246

Effect of exchange rate changes on cash and cash equivalents

 

 
159

 

 
159

Net change in cash and cash equivalents

 
2,843

 
6,914

 

 
9,757

Cash and cash equivalents at the beginning of period

 
35,931

 
60,412

 

 
96,343

Cash and cash equivalents at the end of period
$

 
$
38,774

 
$
67,326

 
$

 
$
106,100